Effect of Low-Fat Diets on Plasma Levels of NF-κB–Regulated Inflammatory Cytokines and Angiogenic Factors in Men with Prostate Cancer
暂无分享,去创建一个
M. Dewhirst | K. Do | B. Aggarwal | W. Demark-Wahnefried | T. Polascik | R. Vollmer | P. Saintigny | A. Kunnumakkara | H. Tran | M. Ruffin | M. Wergin | Shaoyu Yan | Denise C. Snyder | Terry J. Shackleford | S. Yoo | T. Shackleford | J. Heymach
[1] T. Guthrie,et al. Prostate cancer. , 2020, American family physician.
[2] Priya Bhardwaj,et al. Obesity Is Associated with Inflammation and Elevated Aromatase Expression in the Mouse Mammary Gland , 2011, Cancer Prevention Research.
[3] S. Hursting. Inflammatory Talk: Linking Obesity, NF-κB, and Aromatase , 2011, Cancer Prevention Research.
[4] A. Jemal,et al. Global Patterns of Cancer Incidence and Mortality Rates and Trends , 2010, Cancer Epidemiology, Biomarkers & Prevention.
[5] Jun Hee Lee,et al. Dietary and Genetic Obesity Promote Liver Inflammation and Tumorigenesis by Enhancing IL-6 and TNF Expression , 2010, Cell.
[6] Jeffrey S. Morris,et al. Phase II trial of infusional fluorouracil, irinotecan, and bevacizumab for metastatic colorectal cancer: efficacy and circulating angiogenic biomarkers associated with therapeutic resistance. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[7] Edward S. Kim,et al. Distinct patterns of cytokine and angiogenic factor modulation and markers of benefit for vandetanib and/or chemotherapy in patients with non-small-cell lung cancer. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[8] E. Cummins,et al. The Role of NF‐κB in Hypoxia‐Induced Gene Expression , 2009, Annals of the New York Academy of Sciences.
[9] Chun-Yin Huang,et al. Stromal cell‐derived factor‐1/CXCR4 enhanced motility of human osteosarcoma cells involves MEK1/2, ERK and NF‐κB‐dependent pathways , 2009, Journal of cellular physiology.
[10] C. Drevon,et al. Diet-induced obesity increases NF-κB signaling in reporter mice , 2009, Genes & Nutrition.
[11] P. Febbo,et al. The Effects of Varying Dietary Carbohydrate and Fat Content on Survival in a Murine LNCaP Prostate Cancer Xenograft Model , 2009, Cancer Prevention Research.
[12] F. Balkwill. Tumour necrosis factor and cancer , 2009, Nature Reviews Cancer.
[13] W. Demark-Wahnefried,et al. Enterolactone inhibits insulin-like growth factor-1 receptor signaling in human prostatic carcinoma PC-3 cells. , 2009, The Journal of nutrition.
[14] B. Aggarwal,et al. Targeting Inflammatory Pathways for Prevention and Therapy of Cancer: Short-Term Friend, Long-Term Foe , 2009, Clinical Cancer Research.
[15] K. Owzar,et al. Flaxseed Supplementation (Not Dietary Fat Restriction) Reduces Prostate Cancer Proliferation Rates in Men Presurgery , 2008, Cancer Epidemiology Biomarkers & Prevention.
[16] Haiyan Xu,et al. Obesity-Related Upregulation of Monocyte Chemotactic Factors in Adipocytes , 2008, Diabetes.
[17] S. George,et al. Overcoming challenges in designing and implementing a phase II randomized controlled trial using a presurgical model to test a dietary intervention in prostate cancer , 2008, Clinical trials.
[18] W. Demark-Wahnefried,et al. Enterolactone induces apoptosis in human prostate carcinoma LNCaP cells via a mitochondrial-mediated, caspase-dependent pathway , 2007, Molecular Cancer Therapeutics.
[19] S. Chua,et al. Obesity, metabolic syndrome, and prostate cancer. , 2007, The American journal of clinical nutrition.
[20] Robert M Elashoff,et al. Dietary fat reduction and breast cancer outcome: interim efficacy results from the Women's Intervention Nutrition Study. , 2007, Journal of the National Cancer Institute.
[21] Wan-Wan Lin,et al. A cytokine-mediated link between innate immunity, inflammation, and cancer. , 2007, The Journal of clinical investigation.
[22] Laura Herrero,et al. Obesity, inflammation, and insulin resistance. , 2007, Gastroenterology.
[23] B. Aggarwal,et al. Curcumin potentiates antitumor activity of gemcitabine in an orthotopic model of pancreatic cancer through suppression of proliferation, angiogenesis, and inhibition of nuclear factor-kappaB-regulated gene products. , 2007, Cancer research.
[24] I. Thompson,et al. Obesity, Diabetes, and Risk of Prostate Cancer: Results from the Prostate Cancer Prevention Trial , 2006, Cancer Epidemiology Biomarkers & Prevention.
[25] A. Goldfine,et al. Inflammation and insulin resistance. , 2006, The Journal of clinical investigation.
[26] Silvano Sozzani,et al. The chemokine system in diverse forms of macrophage activation and polarization. , 2004, Trends in immunology.
[27] D. Bostwick,et al. Human prostate cancer risk factors , 2004, Cancer.
[28] A. Aljada,et al. Circulating Mononuclear Cells in the Obese Are in a Proinflammatory State , 2004, Circulation.
[29] B. Aggarwal. Nuclear factor-κB: The enemy within , 2004 .
[30] Bharat B. Aggarwal,et al. Nuclear factor-κB: its role in health and disease , 2004, Journal of Molecular Medicine.
[31] C. Gutiérrez,et al. Resistin, adiponectin, ghrelin, leptin, and proinflammatory cytokines: relationships in obesity. , 2004, Obesity research.
[32] A. Aljada,et al. Increase in intranuclear nuclear factor κB and decrease in inhibitor κB in mononuclear cells after a mixed meal: evidence for a proinflammatory effect , 2004 .
[33] M. Terris,et al. Impact of obesity on biochemical control after radical prostatectomy for clinically localized prostate cancer: a report by the Shared Equal Access Regional Cancer Hospital database study group. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[34] B. Lowell,et al. Adipose tissue mass can be regulated through the vasculature , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[35] W. Willett. Dietary fat plays a major role in obesity: no , 2002, Obesity reviews : an official journal of the International Association for the Study of Obesity.
[36] N. Hacohen,et al. Tumor necrosis factor-α suppresses adipocyte-specific genes and activates expression of preadipocyte genes in 3T3-L1 adipocytes: Nuclear factor-κB activation by TNF-α is obligatory , 2002 .
[37] M. Thun,et al. American Cancer Society Guidelines on Nutrition and Physical Activity for Cancer Prevention: Reducing the Risk of Cancer With Healthy Food Choices and Physical Activity , 2002, CA: a cancer journal for clinicians.
[38] W. Demark-Wahnefried,et al. Effect of mammalian lignans on the growth of prostate cancer cell lines. , 2001, Anticancer research.
[39] W. Aronson,et al. Evidence of an inhibitory effect of diet and exercise on prostate cancer cell growth. , 2001, The Journal of urology.
[40] J. Ward,et al. Eotaxin (CCL11) Induces In Vivo Angiogenic Responses by Human CCR3+ Endothelial Cells1 , 2001, The Journal of Immunology.
[41] G. Hallmans,et al. Phytoestrogens and prostate disease. , 2000, The Journal of nutrition.
[42] D. L. Crandall,et al. A Review of the Microcirculation of Adipose Tissue: Anatomic, Metabolic, and Angiogenic Perspectives , 1997, Microcirculation.
[43] T. Rosengart,et al. Vascular endothelial growth factor is the major angiogenic factor in omentum: mechanism of the omentum-mediated angiogenesis. , 1997, The Journal of surgical research.
[44] Q. Hamid,et al. Human monocyte chemoattractant protein (MCP)-4 is a novel CC chemokine with activities on monocytes, eosinophils, and basophils induced in allergic and nonallergic inflammation that signals through the CC chemokine receptors (CCR)-2 and -3. , 1996, Journal of immunology.
[45] P. Leder,et al. Human eotaxin is a specific chemoattractant for eosinophil cells and provides a new mechanism to explain tissue eosinophilia , 1996, Nature Medicine.
[46] B. Aggarwal,et al. Characterization of receptors for human tumour necrosis factor and their regulation by γ-interferon , 1985, Nature.
[47] W. E. Gye,et al. CANCER RESEARCH , 1923, British medical journal.
[48] S. Freedland,et al. Growth inhibitory effect of low fat diet on prostate cancer cells: results of a prospective, randomized dietary intervention trial in men with prostate cancer. , 2010, The Journal of urology.
[49] S. Pizzo,et al. Carbohydrate restriction, prostate cancer growth, and the insulin‐like growth factor axis , 2008, The Prostate.
[50] Cheri L van Patten,et al. Diet and dietary supplement intervention trials for the prevention of prostate cancer recurrence: a review of the randomized controlled trial evidence. , 2008, The Journal of urology.
[51] E. Platz,et al. Obesity and prostate cancer: making sense out of apparently conflicting data. , 2007, Epidemiologic reviews.
[52] T. Giordano,et al. NF-κB in breast cancer cells promotes osteolytic bone metastasis by inducing osteoclastogenesis via GM-CSF , 2007, Nature Medicine.
[53] M. Haluzík,et al. Adipocytokines and cancer. , 2006, Physiological research.
[54] C. Ballantyne,et al. Eotaxin and obesity. , 2006, The Journal of clinical endocrinology and metabolism.
[55] A. Aljada,et al. Increase in intranuclear nuclear factor kappaB and decrease in inhibitor kappaB in mononuclear cells after a mixed meal: evidence for a proinflammatory effect. , 2004, The American journal of clinical nutrition.
[56] B. Aggarwal,et al. Nuclear factor-kappaB: its role in health and disease. , 2004, Journal of molecular medicine.
[57] N. Hacohen,et al. Tumor necrosis factor-alpha suppresses adipocyte-specific genes and activates expression of preadipocyte genes in 3T3-L1 adipocytes: nuclear factor-kappaB activation by TNF-alpha is obligatory. , 2002, Diabetes.
[58] K. Setchell,et al. Production and metabolism of lignans by the human faecal flora. , 1985, The Journal of applied bacteriology.
[59] U. G. Dailey. Cancer,Facts and Figures about. , 2022, Journal of the National Medical Association.